NeoGenomics, Inc. · Fort Myers, FL United States (OTC: NGNM)
| 12701 Commonwealth Dr., Ste. 9 | Phone: 239-768-0600 |
| Fort Myers, FL | Fax: 239-768-0711 |
| 33913 | |
| United States | 
Map This Company |
NeoGenomics, Inc. Rankings
More Companies in These Related Industries: Company Description
NeoGenomics is a fortune teller of sorts. The company offers genetic and molecular testing in four categories to determine a person's genetic predisposition to certain cancers and other diseases. Testing methods include cytogenetics, flourescence in-situ hybridization (FISH), flow cytometry, and molecular genetic testing. The company serves customers including community-based oncologists, pathologists, urologists, hospitals, and other health care facilities through its labs located across the US. Company director Steven Jones controls about 45% of the company through venture capital firm Aspen Select Healthcare.
NeoGenomics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: NGNM Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 185 |
Executives
15 executives listed for NeoGenomics, Inc.'s Fort Myers, FL location.
| Chairman and CEO | Douglas Van Oort | |
|---|---|---|
| President, Chief Science Officer, and Director | Robert Gasparini | |
| CFO | George Cardoza |